Lisa Nibauer's Insider Trades & SAST Disclosures
Lisa Nibauer's most recent trade in Orasure Technologies Inc. was a trade of 1,606 Common Stock done at an average price of $5.1 . Disclosure was reported to the exchange on May 11, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lisa Nibauer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orasure Technologies Inc. | Lisa Nibauer | President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.05 per share. | 11 May 2022 | 1,606 | 123,479 (0%) | 0% | 5.1 | 8,118 | Common Stock |
| Orasure Technologies Inc. | Lisa Nibauer | President-Diagnostics | Grant, award, or other acquisition of securities at price $ 8.86 per share. | 01 Feb 2022 | 34,556 | 125,085 (0%) | 0% | 8.9 | 306,166 | Common Stock |
| Orasure Technologies Inc. | Lisa Nibauer | President-Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.86 per share. | 01 Feb 2022 | 2,606 | 90,529 (0%) | 0% | 8.9 | 23,089 | Common Stock |
| Orasure Technologies Inc. | Lisa Nibauer | President-Diagnostics | Grant, award, or other acquisition of securities at price $ 8.21 per share. | 05 Jan 2022 | 60,901 | 93,135 (0%) | 0% | 8.2 | 499,997 | Common Stock |
| Orasure Technologies Inc. | Lisa Nibauer | EVP BU Lead-Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.55 per share. | 11 May 2021 | 1,606 | 32,234 (0%) | 0% | 9.5 | 15,337 | Common Stock |
| Orasure Technologies Inc. | Lisa Nibauer | EVP BU Lead-Diagnostics | Grant, award, or other acquisition of securities at price $ 15.55 per share. | 01 Feb 2021 | 19,769 | 33,840 (0%) | 0% | 15.6 | 307,505 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges